Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Trudeau. Photo: Dave Chan/Getty Images

The global COVAX vaccine initiative has rolled out detailed plans to distribute vaccines to 145 participants in the first half of 2021.

Zoom in: Canada, which has purchased more doses per capita than any other country, has nonetheless elected to take 1.9 million doses from COVAX.

The big picture: COVAX is the only global mechanism for vaccine distribution and involves nearly every country on Earth, with wealthier countries subsidizing access for poorer ones.

  • The initial phases involve 336 million doses of the Oxford/AstraZeneca vaccine, as well as a much smaller volume of the Pfizer/BioNTech vaccine.
  • By the end of 2021, COVAX aims to ensure that at least 20% of the population in every country has been vaccinated.

Every participant has a right to claim doses, but most rich countries that have secured access through bilateral deals have elected not to do so, at least in the first wave.

  • As Seth Berkley, CEO of the GAVI vaccine alliance, put it to reporters on Wednesday: "Does it help when countries that have a lot of bilateral deals don't take doses? Of course it helps because that means there are more doses available for others."
  • While several other rich countries (Monaco, New Zealand, Saudi Arabia, Singapore) are claiming COVAX doses, Canada is the only G7 country on the list.

What they're saying: "COVAX was always part of the government of Canada's procurement strategy," Minister of International Development Karina Gould told CTV, adding that the government's top priority is ensuring that Canadians have access.

The state of play: While Canada has purchased some 200 million doses for its population of 38 million people, it has only administered one million.

  • Prime Minister Justin Trudeau has faced sharp pressure over the repeated delays in supply, which are due in part to a lack of domestic manufacturing capacity.
  • The other side: Many countries have yet to administer a single dose, and won't until they begin to receive supplies from COVAX.

What to watch: Trudeau has previously committed to donating excess doses to COVAX, but hasn't said whether Canada will do so before it has fully covered its own domestic needs.

Worth noting: North Korea, which has sealed itself off from the world even more tightly during the pandemic and claims to be COVID-free, is also expecting doses from COVAX.

Go deeper: The global line for coronavirus vaccines stretches back to 2023.

Go deeper

U.K. to test mixing COVID-19 vaccines in world-first trial

British Prime Minister Boris Johnson holds a bottle of the Pfizer-BioNTech vaccine as he visits a COVID-19 vaccination centre in Batley, West Yorkshire, England, on Monday. Photo:Jon Super - WPA Pool/Getty Images

The United Kingdom on Thursday launched a new clinical study to test the effects of mixing COVID-19 vaccines.

Why it matters: Per a statement from Oxford University virologist Matthew Snape, chief investigator of the world-first study: "If we do show that these vaccines can be used interchangeably in the same schedule this will greatly increase the flexibility of vaccine delivery."

Bryan Walsh, author of Future
Feb 4, 2021 - Health

Moderna CEO says company needs to adapt with coronavirus variants

Moderna CEO Stéphane Bancel. Photo: Adam Glanzman/Bloomberg via Getty Images

Moderna's CEO Stéphane Bancel tells Axios the company's coronavirus vaccine made it to market in near-record time thanks in part to a unique digital foundation.

The big picture: Moderna is far smaller than many of its pharma competitors, but it made one of the first authorized COVID-19 vaccines. But the company still needs to adapt to a mutating virus — and come up with its next blockbuster product.

Updated Feb 4, 2021 - Sports

Over 500 Australian Open tennis players and staff isolate after COVID case

Serena Williams, pictured signing autographs for fans after beating Bulgaria's Tsvetana Pironkova in their Yarra Valley Classic women's singles tennis match in Melbourne on Wednesday, won't have to isolate. Photo: William West/AFP via Getty Images

One COVID-19 case contracted at a Melbourne quarantine hotel has caused 507 tennis players and staff to go into isolation until they return a negative test result, four days out from the Australian Open beginning.

Why it matters: The first community case in the state of Victoria for 28 days has resulted in new restrictions implemented and the cancelation of all of Thursday's scheduled warm-up games.